Washington · 2025–26 Regular Sessions · Bill

HB 2613: Compounded medications

In committee Last action January 21, 2026: First reading, referred to Health Care & Wellness.

Plain-language summary

HB 2613 is a bill introduced in the Washington House on January 21, 2026. According to its official title, it concerns: Establishing safety and regulatory requirements for compounded medications. Primary sponsor: My-Linh Thai (D). It lists 5 additional sponsors. Most recent recorded action (January 21, 2026): First reading, referred to Health Care & Wellness.

Sponsors

Primary sponsor: My-Linh Thai (Democratic). 5 co-sponsors.